Effectiveness of 5% Dextrose Water (D/W) versus Corticosteroid Injection for Pain Management of Sacroiliac Joint Dysfunction
Main Article Content
Abstract
Background: Corticosteroid injections have been a cornerstone in the management of sacroiliac joint dysfunction (SIJD)-related pain. Recently, alternative approaches to pain management have garnered attention, particularly the use of 5% dextrose water (D/W) injections, which are believed to promote tissue healing and regeneration.
Objective: The purpose of this study was to evaluate the efficacy of 5% dextrose water (D/W) compared to corticosteroid injections for pain management in patients with sacroiliac joint dysfunction (SIJD).
Methods: This experimental study was conducted at Chaudhary Muhammad Akram Teaching and Research Hospital, Lahore, from October 2023 to May 2024. A total of 120 participants aged 18-65 years with clinically diagnosed SIJD were randomly assigned to two groups. Group A (N=60) received three weekly injections of 5% D/W solution, while Group B (N=60) received corticosteroid injections administered weekly over six weeks. Participants were excluded if they were pregnant, breastfeeding, had a history of allergy to the treatment components, or had received SIJ injections within the last three months. Pain intensity, functional disability, and quality of life were assessed using the Visual Analogue Scale (VAS), Oswestry Disability Index (ODI), and a standardized quality of life questionnaire, respectively. Data were analyzed using SPSS version 25, with within-group comparisons made using the Wilcoxon Signed Ranks Test and between-group comparisons using the Mann-Whitney U Test.
Results: Significant improvements were observed in both groups. The VAS scores in the dextrose water group decreased from 5.28 ± 1.71 to 2.58 ± 0.94 (p < 0.001) and in the corticosteroid group from 5.57 ± 1.85 to 3.15 ± 1.33 (p < 0.001). ODI scores improved from 34.27 ± 1.26 to 17.02 ± 3.15 in the dextrose water group (p < 0.001) and from 34.17 ± 1.12 to 19.95 ± 6.11 in the corticosteroid group (p < 0.001). Quality of life scores also showed significant enhancement, improving from 14.43 ± 1.79 to 7.64 ± 0.99 in the dextrose water group (p < 0.001) and from 14.57 ± 1.85 to 8.49 ± 1.98 in the corticosteroid group (p < 0.001).
Conclusion: Both 5% dextrose water and corticosteroid injections significantly reduced pain and improved function and quality of life in patients with sacroiliac joint dysfunction. While corticosteroid injections demonstrated a slightly greater benefit, 5% dextrose water injections are a promising alternative with fewer potential side effects. Further research is recommended to explore long-term outcomes and compare these treatments with other emerging therapies.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Cho H-J, Kwak D-S. Movement Of The Sacroiliac Joint: Anatomy, Systematic Review, And Biomechanical Considerations. Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine. 2021;235(3):357-64.
Coudert P, Dubé-Cyr R, Chaumoitre K, Gille O, Vital J-M, Jouve J-L, et al. Sacroiliac Joint Morphologic Changes From Infancy To Adulthood. The Spine Journal. 2019;19(10):1730-8.
Shin S, Kwak D-S, Lee U-Y. Mobility And Anthropometry Of The Sacroiliac Joint: Range Of Motion And Morphological Characteristics. Biomedical Engineering Letters. 2024:1-10.
Jurik AG, Herregods N. The Sacroiliac Joint Across Ages–What Is Normal? Therapeutic Advances in Musculoskeletal Disease. 2024;16:1759720X241241126.
Simopoulos TT, Manchikanti L, Gupta S, Aydin SM, Kim CH, Solanki DR, et al. Systematic Review Of The Diagnostic Accuracy And Therapeutic Effectiveness Of Sacroiliac Joint Interventions. Pain Physician. 2015;18(5).
Nejati P, Sartaj E, Imani F, Moeineddin R, Nejati L, Safavi M. Accuracy Of The Diagnostic Tests Of Sacroiliac Joint Dysfunction. Journal of Chiropractic Medicine. 2020;19(1):28-37.
Buchanan P, Vodapally S, Lee DW, Hagedorn JM. Successful Diagnosis Of Sacroiliac Joint Dysfunction. 2021;14:3135-43.
Chuang C-W, Hung S-K, Pan P-T, Kao M-C. Diagnosis And Interventional Pain Management Options For Sacroiliac Joint Pain. Tzu Chi Medical Journal. 2019;31(4):207-10.
Gartenberg A, Nessim A, Cho W. Sacroiliac Joint Dysfunction: Pathophysiology, Diagnosis, And Treatment. European Spine Journal. 2021;30:2936-43.
Mekhail N, Levy RM, Deer TR, Kapural L, Li S, Amirdelfan K, et al. Long-Term Safety And Efficacy Of Closed-Loop Spinal Cord Stimulation To Treat Chronic Back And Leg Pain (Evoke): A Double-Blind, Randomised, Controlled Trial. The Lancet Neurology. 2020;19(2):123-34.
Sargut TA, Tkatschenko D, Früh A, Tüttenberg J, Heckert A, Fleck S, et al. Study Protocol For A Prospective, Randomized, Multicenter Trial To Investigate The Influence Of Peripheral Nerve Stimulation On Patients With Chronic Sacroiliac Joint Syndrome (SILENCING). Trials. 2024;25(1):223.
Hauser RA, Lackner JB, Steilen-Matias D, Harris DK. A Systematic Review Of Dextrose Prolotherapy For Chronic Musculoskeletal Pain. Clinical Medicine Insights Arthritis And Musculoskeletal Disorders. 2016;9:139-59.
Patel A, Kumar D, Singh S, Mohan R, Mishra S, Gupta AK, et al. Effect Of Fluoroscopic-Guided Corticosteroid Injection In Patients With Sacroiliac Joint Dysfunction. Cureus. 2023;15(3).
Falowski S, Sayed D, Pope J, Patterson D, Fishman M, Gupta M, et al. A Review And Algorithm In The Diagnosis And Treatment Of Sacroiliac Joint Pain. Journal of Pain Research. 2020:3337-48.
Köroğlu Ö, Örsçelik A, Karasimav Ö, Demir Y, Solmaz İ. Is 5% Dextrose Prolotherapy Effective For Radicular Low Back Pain? Gülhane Tip Dergisi. 2019;61(3):123.
Bayram D, Aliyev D, Özgencil GE. Assessment Of The Efficiency Of Intra-Articular Corticosteroid And Local Anesthetic Injection In Patients With Sacroiliac Joint Dysfunction: 3-Year Treatment Outcomes: A Retrospective Study. Türkiye Klinikleri Tip Bilimleri Dergisi. 2021;41(4):370-6.
Ab Aziz SNF, Zakaria Mohamad Z, Karupiah RK, Che Ahmad A, Omar AS. Efficacy Of Sacroiliac Joint Injection With Anesthetic And Corticosteroid: A Prospective Observational Study. Cureus. 2022;14(4).
Chen AS, Solberg J, Smith C, Chi M, Lowder R, Christolias G, et al. Intra-Articular Platelet Rich Plasma Vs Corticosteroid Injections For Sacroiliac Joint Pain: A Double-Blinded, Randomized Clinical Trial. Pain Medicine. 2021;23(7):1266-71.
Hauser RA, Lackner JB, Steilen-Matias D, Harris DK. A Systematic Review Of Dextrose Prolotherapy For Chronic Musculoskeletal Pain. Clinical Medicine Insights Arthritis And Musculoskeletal Disorders. 2016;9. S39160.
Das G, Das S, Sahoo R, Shreyas S, Kanthi B, Sharma VS. Efficacy Of Cryoneurolysis Versus Intra-Articular Steroid In Sacroiliac Joint Pain: A Retrospective, Case-Control Study. Indian Journal of Anaesthesia. 2023;67(11):1004-8.
Maniquis-Smigel L, Reeves KD, Rosen HJ, Lyftogt J, Graham-Coleman C, Cheng A-L, et al. Analgesic Effect Of Caudal 5% Dextrose In Water In Chronic Low Back Pain: A Randomized Controlled Trial Of Epidural Injection. Anesth Pain Med. 2016;7.